The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial between adjuvant docetaxel and surveillance after radical radiotherapy for intermediate and high risk prostate cancer: Results of SPCG-13 trial.
 
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen
Consulting or Advisory Role - BMS Brazil; Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - BMS Brazil (Inst); Lilly (Inst); Merck Serono (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Roche; Sanofi
 
Marie Hjälm-Eriksson
Speakers' Bureau - Bayer
 
Lennart Astrom
Honoraria - Genzyme; Janssen
 
Timo Marttila
Consulting or Advisory Role - BMS Brazil; Ipsen; Janssen; Roche
Research Funding - Astellas Oncology (Inst); Bayer (Inst); Janssen (Inst); Myovant Sciences (Inst)
Travel, Accommodations, Expenses - Roche; Sanofi
 
Camilla Thellenberg-Karlsson
Consulting or Advisory Role - Bayer (Inst); Sanofi (Inst)
 
Sten Nilsson
No Relationships to Disclose
 
Widmark Anders
Honoraria - Astellas Oncology; Bayer; EXINI Diagnostics
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; EXINI Diagnostics
 
Teppo Huttunen
No Relationships to Disclose
 
Claes Ginman
No Relationships to Disclose